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An integrated, peptide-based approach to site-specific protein 
immobilization for detection of biomolecular interactions†  
Ilmar C. Kruis,a,b Dennis W.P.M. Löwik,b Wilbert C. Boelens,a Jan C.M. van Hestb and Ger J.M. 
Pruijn*a 
We have developed an integrated solution for the site-specific immobilization of proteins on a biosensor surface, which may 
be widely applicable for high throughput analytical purposes. The gold surface of a biosensor was coated with an anti-fouling 
layer of zwitterionic peptide molecules from which leucine zipper peptides protrude. Proteins of interest, the autoantigenic 
proteins La and U1A, were immobilized via a simple incubation procedure by using the complementary leucine zipper 
sequence as a genetically fused binding tag. This tag forms a strong coiled-coil interaction that is stable during multiple 
consecutive measurements and under common regeneration conditions. Visualization of the immobilized proteins of 
interest via antibody binding with multiplex surface plasmon resonance imaging demonstrated 2.5 times higher binding 
responses than when these proteins were randomly attached to the surface via the commonly applied activated ester-
mediated coupling. The proteins could also be immobilized in a leucine zipper-dependent manner directly from complex 
mixtures like bacterial lysates, eliminating the need for laborious purification steps. This method allows the production of 
uniform functional protein arrays by control over immobilized protein orientation and geometry and is compatible with 
high-throughput procedures. 
Introduction 
Interactions between biomolecules play a crucial and complex 
role in biological systems. This makes reliable and sensitive 
methods to study these interactions an important tool in 
(bio)chemical and medical research. A sensitive and versatile 
technique for label-free, real-time detection of such 
interactions is Surface Plasmon Resonance (SPR).1 Like many of 
the methods for detection of biomolecular interactions, it relies 
on immobilization of biologically active molecules on a solid 
surface. The most commonly applied immobilization chemistry 
uses an activated ester functionalized surface to couple primary 
amines, present on the N-terminus or lysine side chains of 
proteins and peptides.2–4 The widely applied amine-based 
coupling chemistry leads to surface heterogeneity due to 
variations in orientation, steric hindrance and multivalent 
binding of the ligand.5 This is suboptimal for sensitivity and 
creates variability between measurements. 
To improve ligand immobilization, several strategies for site-
specific protein immobilization have been developed.6,7 Some 
of these utilize bio-orthogonal reactions like copper-catalyzed 
and strain-promoted ‘click’ chemistry,8–11 oxime ligation10,12 
Staudinger ligation13 or enzymatic coupling reactions as those 
with sortase14 or phosphopantetheinyl transferase.15 Others 
make use of non-covalent binding, such as facilitated by the use 
of affinity tags frequently used for protein purification16–20 or 
peptide tags that bind to the surface matrix, like pMMA.21 More 
alternatives are DNA-directed immobilization22,23 or enzymatic 
modification of the proteins,24–26 like localized biotinylation of a 
specific peptide tag using the BirA enzyme.27 However, these 
methods either rely on separate modification and coupling 
steps of the proteins involved, or have relatively weak binding 
properties.  
Advances in SPR technology also put different demands on the 
immobilization chemistry. Surface Plasmon Resonance Imaging 
(iSPR) is a multiplex variant that is primarily used for the 
visualization of biomolecular interactions, generally on 
microarrays.1 With this approach, instead of a single 
biomolecule, multiple different biomolecules need to be 
immobilized simultaneously. As a consequence, coupling or 
modification steps that need individual optimization for distinct 
biomolecules, are undesirable.  An immobilization method that 
is specific, strong and well controlled, yet versatile and simple 
enough to be used for multiple different biomolecules is not yet 
available.  
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Versatile, specific and strong binding can be found in so-called 
leucine zipper polypeptides. These are coiled-coil binding 
motifs, originating from the bZIP class of transcriptional 
regulator proteins.28 Their structure consists of a heptad repeat 
with a hydrophobic leucine on the binding interface, which gives 
them their name. Next to these leucines, the binding interface 
contains pairs of oppositely charged residues.  By variation of 
these charged residues, affinity and specificity of leucine zippers 
can be engineered, and sets of heterospecific leucine zipper 
peptides have been developed.29,30 By optimizing binding 
strength, binding affinity up to a dissociation constant of 10-15 
M has been obtained, comparable to the well-established 
biotin-streptavidin interaction.31 Zhang et al. successfully 
applied leucine zipper polypeptides for immobilization of 
proteins, although in their approach an additional crosslinking 
reaction was still needed to functionalize the surface.32 
Immobilization with coiled-coil domains was also shown by 
Ferrari et al., using the larger tetra-helical SNARE protein 
complex as connector.33 
The aim of our study was to provide a generic, integrated 
solution for well-controlled immobilization of proteins on gold 
surfaces. Our approach (Figure 1) utilizes a monolayer of short, 
zwitterionic peptides as anti-fouling layer on the gold surface.34 
A fraction of the anti-fouling peptides is extended with a leucine 
zipper. This functionalizes the surface to allow binding of a 
complementary leucine zipper sequence, which is genetically 
fused to the proteins that are to be immobilized. This approach 
allows a strong, well-controlled immobilization of the fusion 
proteins using simple incubation with the functionalized 
surface. The autoantigenic human La and U1A proteins were 
used to demonstrate the applicability of this method35. 
Materials & Methods 
Cloning 
An XhoI restriction site was introduced between the 
oligohistidine tag sequence and the attL1 site of a pDEST17 
vector by site-directed mutagenesis.  Partially overlapping 
oligonucleotides coding for the leucine zipper peptides ER 
(LEIEAAFLERENTALETRVAELRQRVQRLRNRVSQYRTRYGPLGG-
GGK) and RE (LEIRAAFLRQRNTALRTEVAELEQEVQRLENEVSQY-
ETRYGPLGGGGK) flanked by XhoI sites (Biolegio, Nijmegen, The 
Netherlands) were converted to double-stranded molecules by 
PCR, digested by XhoI (New England Biolabs, Ipswitch, MA, USA) 
and the inserts isolated. The inserts were then ligated into the 
XhoI-linearized pDEST17 variant described above. E. coli ccdB 
survival 2 T1R competent cells were transformed with these 
constructs and grown on media with 100 µg/mL carbenicillin 
and 34 µg/mL chloramphenicol. This resulted in the pDNz-VinER 
and pDNz-VinRE plasmids (see Supplementary Figures S1 and 
S2). La and U1A cDNAs were generated by PCR using cDNA 
constructs described previously36,37 and introduced into 
pENTR/TEV/D-TOPO vectors. Subsequently these were 
recombined in an LR-recombination reaction with pDEST17 and 
pDNz vectors using Gateway LR Clonase II mix and  the resulting 
pDEST17-La, pDEST17-U1A, pDNz-VinER-La, pDNz-VinRE-La, 
pDNz-VinER-U1A and pDNz-VinRE-U1A vectors were used to 
transform E. coli TOP10 competent cells. Following plasmid 
isolation, the integrity of all constructs was confirmed by DNA 
sequencing. Cloning supplies were acquired from Invitrogen 
(Carlsbad, CA, USA) and chemicals from Sigma-Aldrich (St. Louis, 
MO, USA). 
 
Protein Expression 
The constructs for the expression of unmodified and N-
terminally leucine zipper-tagged U1A and La proteins were used 
to transform E. coli BL21 AI. An initial overnight culture in 5 mL 
LB was used to inoculate 1.5 L 2TY medium containing 100 
µg/mL ampicillin. The bacteria were cultured at 37 °C and 
expression was induced (at OD 0.7) using 0.1% of L-arabinose 
and 0.5 mM isopropyl β-D-1-thiogalactopyranoside (MP 
Biomedicals, Santa Ana, CA, USA), after which the bacteria were 
cultured overnight at 25 °C. Cells were harvested and 
resuspended in 20 mM Tris-HCl, pH 8.0, 500 mM KCl for Ni-NTA 
affinity purification or PBS for direct immobilization, lysed by 
sonication and cleared by centrifugation for 20 min at 29,000 g. 
For direct immobilization the crude lysates were cleared by 
gradual addition of poly(iminoethylene) to 0.02% and 
centrifugation for 20 min at 29,000 g. Lysates were then frozen 
by liquid nitrogen and stored in single-use aliquots at -80 °C. For 
purification the lysates were incubated with Ni-NTA sepharose 
(IBA Life Sciences, Goettingen, Germany) and the suspension 
was cast in a column. The column was washed with wash buffer 
(20 mM Tris-HCl, pH 8.0, 500 mM KCl, 20 mM imidazole, 10% 
glycerol), wash buffer containing 1 M KCl and wash buffer 
containing 50 mM imidazole. Bound proteins were eluted (20 
Figure 1: Schematic representation of leucine-zipper mediated immobilization. Initially the gold surface of an iSPR biosensor is coated with anti-fouling peptides mixed with 
anti-fouling peptides extended with leucine zippers (1). One or more fusion proteins containing a single complementary leucine zipper peptide are then immobilized on the 
surface by incubation in a microspotter (2). Following immobilization antibody binding to the immobilized proteins is visualized using iSPR (3). 
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mM Tris-HCl, pH 8.0, 100 mM KCl, 500 mM imidazole, 10% 
glycerol) and analysed by SDS-PAGE.  The buffer was then 
exchanged to PBS and samples were concentrated using 10 kDa 
MWCO centrifugation filters (EMD Millipore, Billerica, MA, 
USA).  
 
Peptide Synthesis 
Peptides were synthesized using standard Fmoc chemistry on 
Barlos resin. The resin was swollen in dimethylformamide 
(DMF). Fmoc groups were removed by washing with 20% 
piperidine in DMF while shaking for 20 min. The desired amino 
acids were coupled using 3 eq Fmoc-protected amino acid, 3.3 
eq diisopropylcarbodiimide and 3.6 eq N-hydroxy benzotriazole 
for 40 min up to overnight as indicated by a negative Kaiser 
test.38 After final Fmoc removal, the resin was washed with 
DMF, dichloromethane and methanol and dried. Cleavage from 
the resin was performed using 90% trifluoroacetic acid, 5% 
water, 2.5% triisopropylsilane and 2.5% thioanisole for 5 hours. 
After filtration from the resin the free peptide was precipitated 
in diethyl ether, dried in air, redissolved in water and 
lyophilized. LCMS was performed on a Thermo Finnigan LCQ-
Fleet ESI-ion trap (Thermo Fischer, Breda, The Netherlands) 
equipped with Alltima C18 column, 2.1 x 150 mm, particle size 
3 µm (Alltech Applied Sciences, Breda, Netherlands) using an 
acetonitrile/water gradient with 0.1% formic acid. 
 
Chip preparation 
SensEye Au iSPR sensors (Ssens, Enschede, The Netherlands) 
were cleaned by incubation for 10 min with a 3 : 1 solution of 
sulphuric acid (analysis grade, 95-97%) and 30% hydrogen 
peroxide. Following incubation the chip was rinsed with Milli-Q 
water, ethanol and dried under nitrogen. The surface was 
subsequently coated with a peptide layer by overnight 
incubation with a mixture of 4.75 mM anti-fouling peptide 
(MPA-LHDLHD) and 0.25 mM leucine zipper-anti-fouling fusion 
peptide (RE: MPA-LHDLHDLEIRAAFLRQRNTALRTEVAELEQEVQ-
RLENEVSQYETRYGPLGGGGK or ER: MPA-LHDLHDLEIEAAFL-
ERENTALETRVAELRQRVQRLRNRVSQYRTRYGPLGGGGK ) in Milli-
Q water. After incubation the chip was rinsed thoroughly with 
Milli-Q.  
 
Protein immobilization 
Immobilization of purified, zipper-tagged La to the peptide 
surface was achieved by incubation with 150 ng/mL of the 
protein in PBS containing 0.075% Tween-80 during 1h in a 
Continuous Flow Microspotter (Wasatch Microfluidics, Salt Lake 
City, UT, USA), equipped with a printhead for up to 48 spots of 
approximately 0.1 mm2 each. This incubation was followed by a 
2 min washing step.  
For immobilization of zipper-tagged La using crude bacterial 
lysates, Tween-20 was added to a final concentration of 0.1% 
vol. before similar incubation in the microspotter.  
Covalent immobilization to the peptide-surface was performed 
by activation for 30 min with 50 mM 1-ethyl-3-(3-dimethyl-
aminopropyl)carbodiimide and 250 mM sulfo-(N-hydroxy-
succinimide) (NHS) in 10 mM 2-(N-morpholino)ethanesulfonic 
acid (MES) followed by 1h incubation with 150 ng/mL non-
tagged La protein in sodium acetate pH 4.5. 
 
iSPR analysis 
Performance of the peptide anti-fouling layer was tested by 
preparing a chip as described under chip preparation. For 
comparison a SensEye Easy2Spot-P (Ssens, Enschede, The 
Netherlands) chip with planar NHS ester functionality was used 
and blocked by incubation for 10 min with a 1 M 2-
aminoethanol solution in 10 mM MES pH 5.5. For analysis of the 
non-specific binding to these surfaces, zipper-tagged La and 
serum proteins were diluted in system buffer (PBS containing 
0.075% Tween-80) to final concentrations of 100 μg/mL. 
Binding of these proteins was visualized in an IBIS MX96 iSPR 
over a period of 30 min and analysed using SPRintX software 
(IBIS Technologies, Enschede, The Netherlands) by equalization 
of baselines and determination of the response at the end of 
the binding phase.   
Immobilization of the leucine zipper-tagged protein was 
visualized by preparation of the anti-fouling layer as described 
under chip preparation, followed by 30 min incubation in the 
IBIS MX96 iSPR with 60, 12 and 6 µg/mL zipper-tagged La in 
system buffer, 8 min buffer wash and 1 min regeneration with 
6 M guadinine-HCl.  Analysis was performed with SPRintX 
software and baselines equalized. 
Visualization of the immobilized leucine zipper-tagged proteins 
using antibodies was performed by preparation of a leucine-
zipper functionalized chip as described under chip preparation. 
After immobilization of either the purified proteins or the 
proteins from crude lysate, the first measurement and 
regeneration cycle was performed with system buffer (in case 
of purified proteins) or with 1 M NaCl (in case of the crude 
lysate). Binding of monoclonal antibody (a 1:20 dilution of 
culture supernatant containing 5% serum in system buffer, 
resulting in approximately 1 µg/mL antibody according to SDS-
PAGE analysis) was visualised in the IBIS MX96 iSPR for 40 min, 
followed by 8 min dissociation and 1 min regeneration with 10 
mM glycine-HCl, pH 2.0, unless stated otherwise. Analysis was 
performed with SPRintX software; the chip surface was 
calibrated according to the manufacturer’s instructions, 
baselines were equalized and the response was determined at 
the end of the binding phase, when binding was close to 
equilibrium.  
 
Statistical analyses 
Significance of the differences in protein-binding to the 
antifouling layers and of the antibody-binding to the La protein 
immobilized using a leucine zipper tag or using covalent 
coupling was assessed using an unpaired, one-way ANOVA with 
Tukey-test. Significance between the responses from antibody-
binding to leucine zipper-tagged and untagged protein pairs 
immobilized from crude lysate was assessed using a t-test. All 
statistical analyses were performed using Graphpad Prism 5 
(Graphpad Software, La Jolla, CA, USA). 
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Results and discussion 
Peptide-based self-assembled monolayer for antifouling 
The gold surface of an iSPR chip is typically covered with either 
a dextran hydrogel or a monolayer of carboxyl-terminated 
alkane thiols to avoid non-specific interactions with the gold 
and to provide functional groups for immobilization. Good 
results have also been reported with zwitterionic polymers.39,40 
More recently, Masson and co-workers developed monolayers 
of various zwitterionic peptides with an N-terminal 3-
mercaptopropionic acid (MPA) for surface attachment,34,41 
which provide a similar function. For our purpose, we selected 
the anti-fouling peptide consisting of MPA – Leu – His – Asp – 
Leu – His – Asp, which showed good anti-fouling properties with 
serum as analyte solution.19 This peptide was synthesized using 
Fmoc solid-phase peptide synthesis and its integrity and purity 
were confirmed with LC-MS (Supplementary Figure S3).  
In order to assess anti-fouling performance, non-specific 
binding to the gold surface of an iSPR sensor coated with the 
anti-fouling peptide was investigated by exposing the coated 
surface to high concentrations of either a purified recombinant 
protein or a crude biological sample (serum). The coated surface 
was incubated with a high concentration, 100 μg/mL, of leucine 
zipper-tagged La protein, a putative RNA chaperone which is a 
target for autoantibodies in patients with systemic lupus 
erythematosus and Sjögren’s syndrome,35 or with a similar 
concentration of bovine serum proteins in PBS containing 
0.075% Tween-80. Serum proteins were chosen because they 
were also present during subsequent antibody binding 
experiments (see below). The non-specific binding to the 
peptide layer was compared with binding to a comparable, 
commercially available alternative with a planar, NHS ester-
functionalised surface chemistry blocked with 2-aminoethanol.  
After incubation with the purified protein solution for 30 
minutes, non-specific binding to the iSPR chip was 
approximately equal for both tested layers, while after 
incubation with the serum proteins a considerably lower non-
specific binding was observed with the peptide layer (Figure 2). 
These results showed that the peptide-based layer has indeed 
good anti-fouling properties which are particularly useful for 
measuring antibody interactions. 
 
Leucine zipper based immobilisation for iSPR 
To provide stable immobilization, a leucine zipper pair with high 
affinity, yet low homodimerization properties is desired. Such a 
pair was previously described by Moll and coworkers (peptide 
RE: LEIRAAFLRQRNTALRTEVAELEQEVQRLENEVSQYET-
RYGPLGGGGK and peptide ER: LEIEAAFLERENTALETRVAELR-
QRVQRLRNRVSQYRTRYGPLGGGGK).31 Both leucine zipper 
peptides were synthesized with the anti-fouling sequence and 
3-mercaptopropionic acid at the N-terminus (Supplementary 
Figure S4 and S5). This allowed the attachment of either peptide 
to the gold surface of an iSPR sensor, with the leucine zipper 
peptide protruding from the monolayer of anti-fouling peptides 
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Figure 2: Anti-fouling properties of zwitterionic peptide monolayer. The response due 
to non-specific binding to the peptide monolayer is compared with a commercially 
available chip with planar, NHS ester-functionalised surface chemistry that was 
blocked using 2-aminoethanol. Analytes were 100 μg/mL zipper-tagged La protein 
and approximately 100 μg/mL serum proteins in PBS containing 0.075% Tween-80. 
Bars represent the mean with standard deviation of triplicate analyses. Significance 
of differences (***: P ≤ 0.001; ns: non-significant) was assessed using a one-way 
ANOVA with Tukey test. RU: response units. 
 
Figure 3: Leucine zipper-based immobilization of the La protein on an iSPR surface. a) Sensorgram visualizing binding of 60, 12 and 6 µg/mL of zipper-tagged La protein to the 
complementary zipper peptide on the iSPR surface. Binding was performed in PBS containing 0.075% Tween-80 for 4500 s, after which dissociation conditions (buffer wash) 
were applied for 1500 s. b) Sensorgram visualizing binding of 1 µg/mL anti-La monoclonal antibody SW5 to the La protein, immobilized using standard conditions (150 ng/ml) 
in a microspotter and tagged with a leucine zipper complementary (ER) or non-complementary (RE) to the sensor surface. Binding was performed in PBS containing 0.075% 
Tween-80 for 2400 s, after which dissociation conditions (buffer wash) were applied for 480 s. RU: response units. 
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(Figure 1). A 20-fold molar excess of anti-fouling peptide 
compared to leucine zipper peptide was used to create an anti-
fouling layer which will yield a high density of immobilized 
leucine zipper molecules. 
The cloning of sequences coding for a target protein fused to a 
leucine zipper was performed with the Gateway system42, 
which allows efficient transfer of DNA-fragments between 
plasmids by recombination cloning.  To facilitate high-
throughput cloning of zipper-fusion constructs, the pDEST17 
vector of the Gateway system was modified by the 
incorporation of either the ER or the RE sequence. This resulted 
in the pDNz-VinER and pDNz-VinRE plasmids (see 
Supplementary Figures S1, S2 and Table S1), which after 
incubation with the recombination enzyme mix and the pENTR 
vector containing the cDNA of the target La protein, led to the 
desired leucine zipper fusion expression construct. The 
constructs for the ER- and RE-tagged La protein obtained this 
way, were expressed in E. coli using standard techniques 
(Supplementary Figure S6). After purification, the recovered 
yield of soluble fusion protein was somewhat lower compared 
to the unmodified La protein (data not shown), which might be 
due to an increased tendency of the tagged protein to 
aggregate. 
To immobilize the fusion protein, the leucine zipper-
functionalised surface was incubated with the purified fusion 
protein containing a complementary zipper sequence and the 
immobilization was monitored by iSPR (Supplementary Figure 
S7). The resulting sensorgram (Figure 3a) shows swift 
association of the fusion protein and very slow dissociation 
during a buffer wash, reflecting the very stable non-covalent 
interaction. Consequently, dissociation was negligible during 
the timeframe of SPR measurements. 
Using a continuous flow microspotter with an array of 
microfluidics flow cells, individual ‘spots’ on a sensor chip were 
incubated with either fusion proteins with complementary and 
non-complementary zipper sequences to assess the specificity 
of immobilization. A traditional activated ester coupling was 
performed in parallel to compare leucine zipper-based with 
covalent immobilization. The entire sensor chip was incubated 
with antibodies against the La protein, to visualize the 
immobilized proteins (Figure 3b, Figure 4, supplementary Figure 
S8). The complementary zipper-tagged La protein indeed was 
efficiently immobilized on the surface, whereas the antibody-
binding signals for the non-complementary zipper-tagged 
protein were hardly detectable, indicating that the latter was 
not, or only very inefficiently, immobilized. This substantiates 
the specificity of zipper-based immobilization. Antibody-
binding to zipper-immobilized protein was higher than when 
the protein was covalently bound to the surface. These 
observations reflect those of previous reports6,43 that site-
specific protein immobilization improves the binding response. 
With site-specific immobilization the protein structure is better 
preserved, resulting in less non-binding protein molecules on 
Figure 4: Specificity of leucine zipper-based immobilization detected by antibody 
binding. a) Zipper-tagged La protein was immobilized on a RE leucine zipper-
functionalized sensor surface using, from left to right, a complementary (ER) leucine 
zipper-tag, activated-ester mediated covalent coupling and a non-complementary 
(RE) leucine zipper tag. b) Maximum iSPR responses for anti-La antibody binding to 
the immobilized La protein. Bars represent the mean of triplicate analyses with 
standard deviation for 1 µg/mL anti-La monoclonal antibody SW5 binding in PBS 
containing 0.075% Tween-80. Significance of differences (**: P ≤ 0.01, ***: P ≤ 0.001) 
was assessed using a one-way ANOVA with Tukey test. RU: response units. 
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Figure 5: Relative response of antibody-binding after consecutive regeneration cycles. 
Each cycle consisted of incubation with antibodies, followed by regeneration with 10 
mM glycine-HCl of pH 1.3 or pH 2.0. The mean is shown with standard deviation of 
triplicate analyses with 1 µg/mL anti-La monoclonal antibody SW5 in PBS containing 
0.075% Tween-80. 
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the surface. Also the accessibility of binding sites for the 
antibodies might have been improved due to a more favourable 
orientation of the immobilized protein. In addition, it should be 
noted that we can not exclude the possibility that covalent 
immobilization led to a lower amount of protein immobilized on 
the surface compared to the zipper-mediated immobilization. 
For multiple binding experiments on a single chip it is important 
that the immobilized proteins are resistant to regeneration 
procedures. In typical SPR measurements the ligand is 
immobilized on the surface once and after a binding 
experiment, the bound analyte is removed from the surface by 
a regeneration step, allowing the next binding experiment. For 
bound antibodies this regeneration step is commonly 
performed by a short incubation with a low pH solution.44 For 
optimal regeneration the maximum response should remain 
constant over multiple measurement cycles. With a relatively 
harsh treatment at pH 1.3 the maximum response for the 
binding of anti-La antibody to the zipper-La protein showed a 
clear reduction, with a total decrease after 4 cycles of 
approximately 20%, most likely due to detachment or 
denaturation of the immobilized protein (Figure 5). However, 
under somewhat milder regeneration conditions (pH 2.0) the 
response remained stable and the total decrease after 4 cycles 
was less than 5%. These data indicate that it is possible to 
selectively remove the bound antibody from the surface, while 
the immobilized proteins remain intact and available for binding 
during several consecutive measurements and surface 
regenerations. 
Although the immobilization of proteins is simplified by using 
the leucine zipper-mediated approach, the laborious fusion 
protein expression and purification steps still remain. To reduce 
the amount of work involved, the specificity of leucine zipper-
binding can also be employed to immobilize fusion proteins 
directly from crude bacterial lysates. Besides the previously 
used La protein, a second autoantigenic protein was used, U1A, 
a protein component of the U1 small nuclear ribonucleoprotein 
particle35. The lysates of both fusion proteins were first cleared 
from insoluble material and bacterial DNA by two centrifugation 
steps and precipitation using poly(iminoethylene). The cleared 
lysates were then applied to the zipper-functionalized surface 
and after incubation the surface was rinsed thoroughly to 
remove non-bound material. Immobilized proteins were 
visualized by measuring antibody binding using iSPR. The results 
in Figure 6 show that the leucine zipper-tagged U1A and La 
proteins were indeed immobilized by binding to the 
complementary zipper peptides, while untagged proteins were 
largely washed away, demonstrating that crude cell lysates can 
be employed for leucine zipper-based ligand immobilization.  
While leucine zipper-based immobilization is potentially widely 
applicable, the leucine zipper sequence, although shorter than 
the previously mentioned SNARE complex33, is relatively long 
compared to the moieties used for the execution of covalent 
coupling strategies. This might be a disadvantage in 
experiments where the length of this element is of importance. 
Additionally, the incorporation of a sequence of this length 
increases the risk that it interferes with proper protein folding 
or that steric effects influence the accessibility of important 
regions of the protein. Like other techniques which rely on 
fused peptide tags, such as a sortase- or ybbR-tags14,15, this 
potentially limits the available orientations in which a protein 
can be immobilized and may restrict applications particularly to 
proteins with free N- or C- termini. In contrast to covalent 
immobilization strategies, the non-covalent nature of the 
leucine zipper-tags provides an opportunity to regenerate a 
biosensor surface for the analysis of unrelated biomolecular 
interactions by denaturing the coiled-coil structure.     
Conclusions 
We have demonstrated that leucine zippers as fusion tags can 
successfully be used as an integrated system for well-controlled, 
site-specific immobilization of proteins on surfaces, e.g. for SPR 
analysis.  A peptide-based anti-fouling layer on the bare gold 
surface of an iSPR chip allows functionalization of the surface 
with leucine zippers, without additional coupling or capturing 
steps and with comparable anti-fouling performance to 
commercially available alternatives. Two model proteins were 
genetically fused to a leucine zipper sequence using a high-
throughput cloning procedure, and effectively immobilized on 
such a surface by leucine zipper heterodimerization. Availability 
of the immobilized proteins was subsequently assessed by 
incubation with antibodies, where the antibody binding 
response for protein immobilized using leucine zippers was 
higher than that observed for a classical, random, activated 
ester-based coupling strategy. Although non-covalent and 
reversible, leucine zipper-based immobilization was stable in 
the time-frame of SPR measurements and not affected by 
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Figure 6: Immobilization of leucine zipper-tagged proteins from crude bacterial lysates. 
Antibody-binding response to spots incubated with crude cell lysates containing fusion 
proteins with complementary (RE-tagged protein on ER surface and vice-versa) zipper 
sequences and untagged proteins, on a surface functionalized with the ER peptide 
(black/white) and the RE peptide (grey/white). The bars represent the mean of 
triplicate analyses with standard deviations for 1 µg/mL anti-La monoclonal antibody 
SW5 and anti-U1A monoclonal antibody 9A9 in PBS containing 0.075% Tween-80. 
Significance of differences (**: P ≤ 0.01, ***: P ≤ 0.001) between tagged and untagged 
protein pairs was assessed using a t-test. 
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regeneration conditions commonly used in antibody-based 
assays. This way of immobilization does not necessarily require 
purification of tagged proteins from crude cell lysates, further 
reducing the time and effort involved in immobilization. The 
minimal number of intermediate steps in the immobilization 
procedure minimizes the risk for undesired heterogeneity on 
the surface. The compatibility with high-throughput procedures 
and the simple incubation steps make leucine-zipper mediated 
immobilization ideally suited for applications which involve a 
multitude of proteins to be analysed, like multiplex iSPR. 
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